Tocilizumab use for optic nerve compression in thyroid eye disease: a prospective longitudinal cohort
ConclusionTocilizumab use in optic nerve compression showed promising results as it can be the primary or an alternative treatment option.
Source: International Ophthalmology - Category: Opthalmology Source Type: research
More News: Actemra | Brain | Emergency Medicine | Eyes | Neurology | Opthalmology | Rehabilitation | Study | Thyroid